These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7712575)

  • 1. [Clinical analysis of 60 cases of nosocomal pneumonias].
    Yu L; Chen YL; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):303-4, 320. PubMed ID: 7712575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
    Cheng WC; Xiang XD; Chen P; Zan JN
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):567-9. PubMed ID: 12516407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy.
    Costa SF; Newbaer M; Santos CR; Basso M; Soares I; Levin AS
    Int J Antimicrob Agents; 2001 Feb; 17(2):147-50. PubMed ID: 11165120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Furtado GH; d'Azevedo PA; Santos AF; Gales AC; Pignatari AC; Medeiros EA
    Int J Antimicrob Agents; 2007 Oct; 30(4):315-9. PubMed ID: 17631984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immune Signaling Activated by MDR Bacteria in the Airway.
    Parker D; Ahn D; Cohen T; Prince A
    Physiol Rev; 2016 Jan; 96(1):19-53. PubMed ID: 26582515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
    Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
    Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between isolation of extended spectrum beta-lactamase-producing Klebsiella pneumoniae and course of hospital-acquired pneumonia].
    Vitkauskiene A; Giedraitiene A; Dudzevicius V; Sakalauskas R
    Medicina (Kaunas); 2007; 43(10):778-83. PubMed ID: 17998794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Vitkauskiene A; Sakalauskas R; Dudzevicius V
    Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipseudomonic effect of macrolides. Experience in a case of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa without response to antibiotic therapy].
    Barbero JM; Arranz A; Rebollar A; Culebras A; García M; Agudo R; Pérez L; Montero E
    Rev Esp Quimioter; 2018 Feb; 31(1):72-74. PubMed ID: 29390604
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilator-associated pneumonia caused by colistin-resistant KPC-producing Klebsiella pneumoniae: a case report and literature review.
    Viaggi B; Sbrana F; Malacarne P; Tascini C
    Respir Investig; 2015 May; 53(3):124-8. PubMed ID: 25951099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
    Kang CI; Kim SH; Bang JW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    J Korean Med Sci; 2006 Oct; 21(5):816-22. PubMed ID: 17043412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
    Sutherland CA; Verastegui JE; Nicolau DP
    Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):39. PubMed ID: 27316973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.